Grace Lytle

Grace Lytle is an experienced executive in the field of ocular medical affairs, currently serving as the Executive Ocular Medical Director, Oncology, Medical Affairs + Health Impact at AbbVie since February 2024. Prior to this role, Grace held the position of Executive Ocular Medical Director at ImmunoGen, Inc. until its acquisition by AbbVie. Grace's extensive experience includes leadership roles such as Vice President of Global Medical Affairs at Glaukos Corporation, where responsibilities encompassed driving scientific strategies for corneal health and glaucoma treatments, as well as Vice President of Medical Affairs at Avedro, Inc., managing global strategies for corneal cross-linking. Earlier positions include Senior Medical Director at Avellino Lab, with a focus on clinical resources for corneal conditions, and various roles at Avedro, Inc. focused on clinical applications and medical communications. Grace's educational background includes a Doctor of Optometry degree from the New England College of Optometry and a Bachelor’s degree in Behavioral Neuroscience from Northeastern University.